Your browser doesn't support javascript.
loading
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.
Boland, Julia L; Zhou, Qin; Martin, Madhuri; Callahan, Margaret K; Konner, Jason; O'Cearbhaill, Roisin E; Friedman, Claire F; Tew, William; Makker, Vicky; Grisham, Rachel N; Hensley, Martee L; Zecca, Nicholas; Iasonos, Alexia E; Snyder, Alexandra; Hyman, David M; Sabbatini, Paul; Aghajanian, Carol; Cadoo, Karen A; Zamarin, Dmitriy.
Afiliação
  • Boland JL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhou Q; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Martin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Callahan MK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Konner J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • O'Cearbhaill RE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Friedman CF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Tew W; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Makker V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Grisham RN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Hensley ML; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Zecca N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Iasonos AE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Snyder A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Hyman DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Sabbatini P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Cadoo KA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA.
  • Zamarin D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: Zamarind@mskcc.org.
Gynecol Oncol ; 152(2): 251-258, 2019 02.
Article em En | MEDLINE | ID: mdl-30470581

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Carcinoma Epitelial do Ovário / Imunoterapia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Carcinoma Epitelial do Ovário / Imunoterapia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article